
|Articles|April 1, 2002
Manufacturer, FDA revise isotretinoin labeling
Dermatologists and other isotretinoin (Accutane) prescribers soon will be mailed a new brochure on how to recognize psychiatric disorders in the pediatric population.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Delgocitinib Advances to Phase 3 Evaluation for Lichen Sclerosus
2
The Aesthetic Edge: January 2026
3
LEVEL UP Study Shows Benefits of Switching From Dupilumab to Upadacitinib in AD
4
Case-Based Perspectives on Biologic Treatment for Hidradenitis Suppurativa
5



















